![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
Zug, Switzerland:
- Galderma, the pure-play dermatology class chief, pronounces its intention to discover alternatives to construct its fifth manufacturing plant in Singapore
- Supported by the Singapore Economic Development Board, the brand new facility is anticipated to enhance Galderma’s manufacturing capability by up to 350 million items per yr, in response to persevering with demand for premium science-based merchandise in the Dermo-cosmetics sector
Reaffirming its daring ambition to develop into the main dermatology firm in the world, Galderma at present introduced its intention to increase its manufacturing and innovation footprint in the Asia-Pacific area, with help from the Singapore Economic Development Board. Galderma intends to discover alternatives to construct a fifth manufacturing plant with a excessive diploma of digitalization and automation in Singapore in response to rising shopper demand and to help long-term sustainable progress over the approaching years.
This press launch options multimedia. View the total launch right here: https://www.businesswire.com/news/home/20221012005570/en/
Mr. Tan Kong Hwee, Executive Vice President of the Singapore Economic Development Board (EDB) and Flemming Ørnskov, M. D., MPH, Chief Executive Officer of Galderma (Photo: Galderma)
The announcement comes as a part of Galderma’s strategic manufacturing roadmap, aligned with the corporate’s distinctive Integrated Dermatology Strategy. Following a document 2021 efficiency, Galderma has demonstrated sturdy industrial and monetary efficiency in the primary half of 2022, with continued sturdy progress throughout product classes. In explicit, Dermo-cosmetics has grown by 31% year-on-year on a continuing forex foundation, fueled by the sturdy efficiency of Cetaphil® pushed by e-commerce and launches in China and the remainder of Asia.
|
“Our goal is to support our strong growth trajectory in the long-term with a new manufacturing plant that will significantly increase our capacity to serve consumers with premium brands from our differentiated Dermo-cosmetics portfolio across geographies, and primarily throughout our key markets in Asia-Pacific. We sincerely thank the Economic Development Board of Singapore for its support, and we look forward to further collaboration to bring this exciting project to life.”
FLEMMING ØRNSKOV, M.D., MPH
|
With its premiumization technique and broad channel publicity, Galderma is effectively positioned to capitalize on rising shopper demand throughout Asia-Pacific, the place the compelling dermatology market has remained on a constant progress trajectory, with strong demand for premium science-based merchandise. Galderma’s new manufacturing plant in Singapore is anticipated to enhance the corporate’s whole capability for Dermo-cosmetics premium model manufacturing by up to 350 million items a yr, in line with anticipated progress in the area.
|
“We welcome Galderma’s expansion in Singapore, driven by the need to meet growing demand and sophistication of consumers in Asia. This adds to the growing number of consumer healthcare companies that use Singapore as a hub for innovation. We are also pleased that Galderma’s first Dermo-cosmetics manufacturing plant in Asia will be landing in Singapore, as it will leverage and contribute to Singapore’s advanced manufacturing capabilities. There will be many exciting innovation and manufacturing job opportunities that Galderma will create with this investment.”
MR TAN KONG HWEE
|
Galderma already advantages from a well-established presence in Singapore, which isn’t solely a key marketplace for Galderma’s revolutionary portfolio of cutting-edge manufacturers and companies, but in addition serves as its Asia-Pacific regional hub.
About Galderma
Galderma is the pure-play dermatology class chief, current in roughly 90 international locations. We ship an revolutionary, science-based portfolio of premium flagship manufacturers and companies that spans the total spectrum of the fast-growing dermatology market by Injectable Aesthetics, Dermo-cosmetics and Therapeutic Dermatology. Since our basis in 1981, we have now devoted our focus and ardour to the human physique’s largest organ – the pores and skin – assembly particular person shopper and affected person wants with superior outcomes in partnership with healthcare professionals. Because we perceive that the pores and skin we’re in shapes our lives, we’re advancing dermatology for each pores and skin story.
For extra data: www.galderma.com
View supply model on businesswire.com: https://www.businesswire.com/news/home/20221012005570/en/
